Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

11,319 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    US Commodity Futures Trading Commission Fines Investment Bank For Attempted Manipulation Of Benchmark Swaps Rate

    On February 1, 2018, the CFTC issued an order settling charges against the US investment arm of an international bank for attempted manipulation of the US dollar International Swaps ...
    United StatesFinance and Banking
    A&O Shearman
    A&O Shearman
  • Article

    US Federal Deposit Insurance Corporation Publishes Article Regarding Enhancing Banks' Cybersecurity Programs

    The publication also provides a summary of actions taken by the FDIC individually and with other regulators in response to the increase in cyber threats.
    United StatesFinance and Banking
    A&O Shearman
A&O Shearman
  • Article

    $125 Million Settlement For Alleged FCA Violations

    In a settlement with the US DOJ, Kindred Healthcare, Inc., a skilled nursing and long-term care company, has agreed to pay the federal government more than $125 million for alleged False Claims Act violations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Article

    Another Healthcare Fraudster Convicted

    The case was brought as part of the Medicare Fraud Strike Force, which operates in nine cities across the country, and has charged nearly 2,000 defendants who have collectively billed more than $6 billion.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Article

    Beware the Federal Travel Act in Healthcare Fraud Cases

    Another doctor pleaded guilty in the Biodiagnostic Laboratory Services LLC (BLS) test referral scheme in New Jersey.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Bigger Apparently Is Better In DOJ's Eyes – DOJ Piles On As False Claims Act CMPs Set To Almost Double On August 1, 2016

    Today the Department of Justice published an interim final rule with request for comments that applies an inflation adjustment to civil monetary penalty (CMP) amounts assessed by the Department, as mandated by the Bipartisan Budget Act of 2015.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Charting The DOJ's Record Breaking Year For False Claims Act Enforcement

    The US Department of Justice (DOJ) and whistleblowers were party to a record number of False Claims Act settlements and judgments in fiscal year 2023.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CMS Gains Exclusion Authority: What Healthcare Providers Should Be Watching

    The Trump Administration's recent announcement regarding CMS exclusion authority represents a potentially transformative shift in federal healthcare enforcement. This development could significantly expand the government's capacity to exclude providers from Medicare and Medicaid participation, raising critical questions about how responsibilities will be divided between CMS and OIG. Healthcare organizations with substantial federal program participation face new compliance considerations as enforcement mech
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    Court Dismisses "Qui Tam" False Claims Act Complaint

    As 2013 came to a close, the United States District Court dismissed a complaint filed under the federal False Claims Act and the Anti-Kickback Law – and numerous state and local laws – alleging a kickback scheme associated with hemophilia medication.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Department Of Justice 2018 In Review

    Policy Shifts at the Department of Justice – 2018 in Review provides an easily navigated yet detailed summary of significant developments at the Department of Justice (DOJ) focusing on fraud and abuse
    United StatesFood, Drugs, Healthcare, Life Sciences
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Article

    DOJ Says Noncompliance With Manuals Is Not Enough For Prosecution – Or Is It?

    In December 2018, the Department of Justice (DOJ) formalized its position on limiting the use of guidance documents issued by federal agencies to govern its prosecution decisions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Excluded Physician Not Precluded From Collecting Pre-Exclusion Receivables According To OIG Advisory Opinion

    The Advisory Opinion was requested by a physician who was excluded for 20 years from Medicare participation as part of a a criminal plea and settlement of a civil False Claims Act settlement.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    False Claims Act Case May Continue Against Medicare Advantage Insurer

    In United States ex rel. Benjamin Poehling v. UnitedHealth Group, Inc. et al., Case No. CV 16-08697 (C.D. Cal. Feb. 18, 2018), the court dismissed only half of the claims in a qui tam case...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    Following Input On Stark Law Changes, CMS Evaluating Anti-Kickback Changes

    On the heels of the end of the comment period for input on reducing the regulatory burdens of the Physician Self-referral Law (also known as the "Stark Law") on August 24, the Department of Health and Human Services, ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    HHS Finalizes New Protections Under The AKS And Stark Law For Value-Based Arrangements And Other Significant Revisions To Modernize Fraud And Abuse Rules

    On Friday, November 20, 2020, the Department of Health and Human Services (HHS) released four significant Final Rules, including the Office of Inspector General (OIG) rule:
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Justice Department Doubles Penalties for Healthcare Fraud

    In June 30, the U.S. Department of Justice (DOJ) released an interim final rule that implements provisions of the Bipartisan Budget Act of 2015 (Act) which updated civil monetary penalties assessed or enforced by the DOJ that had not been changed for years.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Laboratories Compensating Physicians For Ordering Tests Under Investigation

    Health Diagnostic Laboratory in Virginia and several other labs are under investigation by the Office of Inspector General and Justice Department.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Nurses Hit Hardest by Medicare and Medicaid Exclusions

    A July 19 article in Bloomberg BNA's Health Care Fraud Report and other publications, "Nurses Hit Hardest by Medicare and Medicaid Exclusions," discussed the exclusion of nurses and physicians from participation in the Medicare and Medicaid programs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Office Of Inspector General Advisory Opinion Addresses Hospital Management Services

    The Office of Inspector General (OIG) of the Department of Health and Human Services posted an Advisory Opinion today addressing a hospital system's proposal to lease administrative employees...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    OIG Fraud Alert Cautions Against Sham Medical Director Arrangements

    The HHS OIG recently issued a brief fraud alert reminding physicians that inappropriate compensation arrangements may lead to enforcement actions under the federal anti-kickback statute and Civil Monetary Penalties Law.
    United StatesFood, Drugs, Healthcare, Life Sciences
    BakerHostetler
    BakerHostetler
  • Showing 601–620 of 11319 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics